Drug Susceptibility Evaluation of an Influenza A(H7N9) Virus by Analyzing Recombinant Neuraminidase Proteins.

about

Drug Susceptibility Evaluation of an Influenza A(H7N9) Virus by Analyzing Recombinant Neuraminidase Proteins.

Item

http://www.wikidata.org/entity/Q41932777

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Drug Susceptibility Evaluation ...... binant Neuraminidase Proteins.

@en

type

Item

label

Drug Susceptibility Evaluation ...... binant Neuraminidase Proteins.

@en

prefLabel

Drug Susceptibility Evaluation ...... binant Neuraminidase Proteins.

@en

P1476

Drug Susceptibility Evaluation ...... binant Neuraminidase Proteins.

@en

P2093

Charles T Davis

http://www.w3.org/2001/XMLSchema#string

Erin Hodges

http://www.w3.org/2001/XMLSchema#string

Hua Yang

http://www.w3.org/2001/XMLSchema#string

James Stevens

http://www.w3.org/2001/XMLSchema#string

Katrina Sleeman

http://www.w3.org/2001/XMLSchema#string

Larisa V Gubareva

http://www.w3.org/2001/XMLSchema#string

Tatiana Baranovich

http://www.w3.org/2001/XMLSchema#string

Zhu Guo

http://www.w3.org/2001/XMLSchema#string

P2860

The VASP tetramerization domain is a right-handed coiled coil based on a 15-residue repeat

Structural Characterization of the 1918 Influenza Virus H1N1 Neuraminidase

Influenza A Virus N5 Neuraminidase Has an Extended 150-Cavity

Characterization of two distinct neuraminidases from avian-origin human-infecting H7N9 influenza viruses

The CCP4 suite: programs for protein crystallography

Antiviral susceptibility of variant influenza A(H3N2)v viruses isolated in the United States from 2011 to 2013

Human infection with a novel avian-origin influenza A (H7N9) virus

Unique Determinants of Neuraminidase Inhibitor Resistance among N3, N7, and N9 Avian Influenza Viruses.

Mammalian adaptation of influenza A(H7N9) virus is limited by a narrow genetic bottleneck.

Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance.

P304

S566-S574

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIW625

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

suppl_4

http://www.w3.org/2001/XMLSchema#string

P478

216

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28934455

http://www.w3.org/2001/XMLSchema#string